Soliton ID, Inc. has announced the initiation of a private offering aimed at raising $1 million through Simple Agreements for Future Equity (SAFEs). This strategic move is significant as it reflects the company's approach to secure funding while navigating the complexities of public disclosures.
This offering is particularly relevant in the context of the technology sector, where innovative funding methods are becoming increasingly popular. The filing indicates that Soliton ID has already raised $105,000, leaving a remaining balance of $895,000 to be raised. This demonstrates an early interest from investors in the company's future potential.
Background
Soliton ID, Inc. is incorporated in Delaware and operates from Montreal, Quebec, Canada. The company was established in 2026 and is classified under the SIC description of Other Technology. The firm has not publicly listed any stock ticker or exchange information as of this filing.
What the Filing Says
The SEC filing, dated October 29, 2026, outlines the details of the private offering under Rule 506(b). It states, "Total offering amount: $1,000,000; total amount sold: $105,000; total remaining: $895,000." The company is not accepting any minimum investment, which could encourage a broader range of investors to participate.
Impact
This private offering may affect a variety of stakeholders, including potential investors and the broader technology sector. Soliton ID's decision to utilize SAFEs may inspire other companies in the industry to consider similar fundraising strategies, particularly those looking to avoid the complexities of traditional public offerings.
What's Next
The filing does not say what happens next. However, with the initial funds raised, Soliton ID may focus on attracting additional investors to reach its target amount.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










